659
Views
9
CrossRef citations to date
0
Altmetric
Poison Centre Research

Poison control center experience with tianeptine: an unregulated pharmaceutical product with potential for abuse

, , ORCID Icon &
Pages 1155-1158 | Received 08 Mar 2018, Accepted 09 May 2018, Published online: 25 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

William Rushton, Brian Whitworth, Julie Brown, Michael Kurz & Jessica Rivera. (2021) Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health. Clinical Toxicology 59:2, pages 152-157.
Read now

Articles from other publishers (8)

Brayden Kameg. (2022) Tianeptine. Journal of Addictions Nursing 33:4, pages 331-332.
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Gaspard Montandon. 2022. Respiratory Neurobiology - Physiology and Clinical Disorders, Part I. Respiratory Neurobiology - Physiology and Clinical Disorders, Part I 339 355 .
Adina Badea, Rohit Ghosh, Kara L Lynch & Alan H B Wu. (2021) Lack of Cross-Reactivity of Tianeptine with Tricyclic Antidepressant Immunoassays. Journal of Analytical Toxicology 45:3, pages e8-e9.
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Paul Trowbridge & Alexander Y. Walley. (2019) Use of Buprenorphine-Naloxone in the Treatment of Tianeptine Use Disorder. Journal of Addiction Medicine 13:4, pages 331-333.
Crossref
. (2019) Tianeptine abuse/withdrawal. Reactions Weekly 1735:1, pages 254-254.
Crossref
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances 3 49 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.